3/14/22 18:03 | 3/10/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.dm | 0 | 0.00 | 0 | 8 | 39 | 27 | D | | | | | | | | | | | | | | |
12/7/21 20:00 | 12/3/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.d | 0 | 0.00 | 0 | 27 | | 22 | D | | | | | | | | | | | | | | |
9/14/21 21:44 | 9/10/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.d | 0 | 0.00 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
3/12/21 17:47 | 3/10/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.d | 0 | 0.00 | 0 | 5 | 54 | 13 | D | | | | | | | | | | | | | | |
3/12/21 17:37 | 1/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.a | 236 | 14.43 | 0 | 16 | 77 | 38 | D | | | | | | | | | | | | | | |
1/20/21 18:07 | 1/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.d | 345 | 13.79 | 0 | 25 | | 20 | D | | | | | | | | | | | | | | |
1/20/21 18:07 | 1/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | S.d | -5,380 | 215.20 | 0 | -25 | -56 | 20 | D | | | | | | | | | | | | | | |
6/26/20 16:33 | 6/24/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.dm | 620 | 8.86 | 0 | 70 | | 20 | D | | | | | | | | | | | | | | |
6/26/20 16:33 | 6/24/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | S.dm | -5,312 | 75.88 | 0 | -70 | -78 | 20 | D | | | | | | | | | | | | | | |
5/13/20 16:38 | 5/11/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | M.d | 147 | 5.86 | 0 | 25 | | 20 | D | | | | | | | | | | | | | | |
5/13/20 16:38 | 5/11/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | CBO,COO | S.d | -1,510 | 60.40 | 0 | -25 | -56 | 20 | D | | | | | | | | | | | | | | |
7/12/19 16:13 | 7/10/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | Chief Bu | M.dm | 117 | 5.86 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |
7/12/19 16:13 | 7/10/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Klein Lawrence Otto | MA | O | Chief Bu | S.dm | -1,000 | 50.02 | 0 | -20 | -50 | 20 | D | | | | | | | | | | | | | | |